Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol versus oxytocin for retained placenta after vaginal delivery
IRCT2015102824754N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of misoprostol and oxytocin in retained placenta (2 arms), sponsored by Tehran University of Medical Sciences. Started May 2016; status: completed.
02
Drugs
misoprostoloxytocin
03
Conditions
retained placenta
Beyond the preview
Go deeper on IRCT2015102824754N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015102824754N1.